![Cluepoint](/images/a171694e-1aa9-4a23-bc9c-41c896fb1113/sp/Cluepoint.png)
![Cluepoint](/images/47c8804b-fb3c-4a39-8ce5-1d2a996390ea/sp-l/Cluepoint-2.png)
Cluepoint
Liberty advises the management team of CluePoints on its investment by EQT
Dan, Miranda and Tim have been very helpful and highly responsive throughout the process. Dan’s knowledge and experience combined with his level-headed approach make him an excellent advisor. It is comforting to have Dan in your corner during a transaction. He works to get a good outcome for Management whilst ensuring alignment with investor interests. We are delighted that EQT has invested in CluePoints, and we’re excited about the future.
Andy Cooper
CEO of CluePoints
Liberty Corporate Finance is delighted to announce they have advised the management team of CluePoints S.A. on the recent majority investment by EQT.
CluePoints is a leading provider of AI-driven software solutions for clinical data review. It’s cloud-based software platform for Risk-Based Quality Management and data quality oversight in clinical trials is designed to enable safer and more efficient processes and to improve data integrity and risk compliance.
Founded in 2012 and headquartered in Belgium, CluePoints is a premier software provider for RBQM and data quality oversight in clinical trials. Applying advanced statistics and machine learning, and harnessing over 10 years of clinical trials knowledge, CluePoints' proprietary algorithms help drive positive outcomes for pharmaceutical and biotech companies, contract research organizations and other customers.
The Company offers an end-to-end value proposition from initial risk identification to ongoing tracking and monitoring of issues and discrepancies throughout the drug development process. With more than 9,500 platform users, CluePoints has helped de-risk more than 1,600 studies and has detected over 142,000 issues for its customers, which include many of the top 20 largest pharma companies.
As healthcare innovation accelerates, EQT will apply its expertise in investing in healthcare and throughout the tech value-chain to help CluePoints to cement its leading global position.
![](/images/e512407f-a67f-4099-9f11-d1424f72eb8d/sp/Liberty_CirclePortraits_Dec2021_Grey_Dan-copy.png)
Collaborating with Andy and the entire management team during this pivotal period for Cluepoints has been a real pleasure. We look forward to seeing the growth that this dynamic leadership can deliver in the next stage of their journey supported by EQT.
Dan Martinez
Partner
+44 (0) 7398 212 298
dan.martinez@liberty-cf.com